Bristol-Myers matches earnings forecast, helped by low taxes

Thu Apr 25, 2013 7:52am EDT

(Reuters) - Bristol-Myers Squibb Co (BMY.N) reported lower first-quarter earnings, in line with forecasts, thanks to unexpectedly lower taxes and sharply higher sales of its treatments for melanoma, leukemia and diabetes.

The company on Thursday said it earned $609 million, or 37 cents per share, in the quarter. That compared with $1.1 billion, or 64 cents per share in the year-earlier period.

(Reporting By Ransdell Pierson; Editing by Gerald E. McCormick)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.